Selonsertib

CAS: 1448428-04-3

Ref. 3D-FC157241

Produktinformation

• Name: Selonsertib
• Synonyme: 5-(4Cyclopropyl- 1H- imidazol- 1- yl) - 2- fluoro- N- (6- (4- isopropyl- 4H- 1, 2, 4- triazol- 3- yl) pyridin- 2- yl) - 4- methylben zamide

Beschreibung

Selonsertib is a highly selective inhibitor of the ATP-binding cassette transporter (ABCA1) that belongs to the class of glp-1 analogues. It is used in combination with other drugs for the treatment of bowel disease, autoimmune diseases, and skin cancer. Selonsertib has been shown to be active against a number of cell types and is also effective in models of metabolic disorders such as hepatic steatosis and kidney fibrosis. Selonsertib blocks ABCA1 by binding to its ATP-binding site, inhibiting cholesterol efflux from cells. This drug may work by restoring mitochondrial membrane potential, which may help prevent or reverse cellular damage caused by oxidative stress.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 445.49 g/mol
• Formel: C₂₄H₂₄FN₇O
• Reinheit: Min. 95%
• InChl: InChI=1S/C24H24FN7O/c1-14(2)32-13-27-30-23(32)19-5-4-6-22(28-19)29-24(33)17-10-21(15(3)9-18(17)25)31-11-20(26-12-31)16-7-8-16/h4-6,9-14,16H,7-8H2,1-3H3,(H,28,29,33)
• InChI Key: InChIKey=YIDDLAAKOYYGJG-UHFFFAOYSA-N
• SMILES: Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1